Dynavax Technologies Corporation announced that Kelly MacDonald has been appointed Chief Financial Officer. Ms. MacDonald will join the company effective March 1, 2021. As previously announced, after 14 years at Dynavax, Chief Financial Officer Michael Ostrach is retiring. Mr. Ostrach has agreed to remain available as an advisor to the Company thereafter. Ms. MacDonald joins Dynavax from Ironwood Pharmaceuticals where she held roles of increasing responsibility. In her final role at Ironwood Ms. MacDonald served as Chief Accounting Officer and Vice President, Finance where she led the Company's corporate accounting and finance processes, enterprise risk management, treasury and capital allocation strategy. While at Ironwood, she also held various other managerial roles, providing finance and accounting support for the company's strategic planning, R&D portfolio management, global business development, product launches and commercial execution. Prior to joining Ironwood, Kelly was a Manager in the Health Industries Assurance Practice at PricewaterhouseCoopers, primarily serving clients in life sciences and technology sectors.